ZA201704793B - Treatment of retinal degeneration using progenitor cells - Google Patents

Treatment of retinal degeneration using progenitor cells

Info

Publication number
ZA201704793B
ZA201704793B ZA2017/04793A ZA201704793A ZA201704793B ZA 201704793 B ZA201704793 B ZA 201704793B ZA 2017/04793 A ZA2017/04793 A ZA 2017/04793A ZA 201704793 A ZA201704793 A ZA 201704793A ZA 201704793 B ZA201704793 B ZA 201704793B
Authority
ZA
South Africa
Prior art keywords
treatment
progenitor cells
retinal degeneration
retinal
degeneration
Prior art date
Application number
ZA2017/04793A
Other languages
English (en)
Inventor
Ian Harris
Jing Cao
Nadine Sophia Dejneka
Original Assignee
Janssen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Biotech Inc filed Critical Janssen Biotech Inc
Publication of ZA201704793B publication Critical patent/ZA201704793B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2017/04793A 2014-12-16 2017-07-14 Treatment of retinal degeneration using progenitor cells ZA201704793B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462092658P 2014-12-16 2014-12-16
US201562236732P 2015-10-02 2015-10-02
PCT/US2015/063931 WO2016099949A2 (en) 2014-12-16 2015-12-04 Treatment of retinal degeneration using progenitor cells

Publications (1)

Publication Number Publication Date
ZA201704793B true ZA201704793B (en) 2019-01-30

Family

ID=56110114

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2017/04793A ZA201704793B (en) 2014-12-16 2017-07-14 Treatment of retinal degeneration using progenitor cells

Country Status (15)

Country Link
US (1) US20160166619A1 (cg-RX-API-DMAC10.html)
EP (1) EP3233096A4 (cg-RX-API-DMAC10.html)
JP (1) JP2018500325A (cg-RX-API-DMAC10.html)
KR (1) KR20170094368A (cg-RX-API-DMAC10.html)
CN (1) CN107249608A (cg-RX-API-DMAC10.html)
AU (1) AU2015363088A1 (cg-RX-API-DMAC10.html)
BR (1) BR112017012581A2 (cg-RX-API-DMAC10.html)
CA (1) CA2970641A1 (cg-RX-API-DMAC10.html)
MX (1) MX2017007953A (cg-RX-API-DMAC10.html)
PH (1) PH12017501028A1 (cg-RX-API-DMAC10.html)
RU (1) RU2017124983A (cg-RX-API-DMAC10.html)
SG (1) SG11201704668PA (cg-RX-API-DMAC10.html)
TW (1) TW201632620A (cg-RX-API-DMAC10.html)
WO (1) WO2016099949A2 (cg-RX-API-DMAC10.html)
ZA (1) ZA201704793B (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
MX2018006729A (es) * 2015-12-04 2018-11-09 Janssen Biotech Inc Tratamiento de la degeneracion de la retina mediante el uso de celulas progenitoras.
JP6799248B2 (ja) * 2016-09-28 2020-12-16 澁谷工業株式会社 細胞シートの切断方法
WO2018102174A1 (en) * 2016-12-01 2018-06-07 Janssen Biotech, Inc. Treatment of retinal degeneration using progenitor cells
GB201703058D0 (en) 2017-02-24 2017-04-12 Ucl Business Plc Biomarkers
KR102091567B1 (ko) * 2018-06-15 2020-03-20 인하대학교 산학협력단 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물
CN109456937A (zh) * 2018-12-27 2019-03-12 广州赛莱拉干细胞科技股份有限公司 一种制备子宫内膜干细胞的培养基以及制备方法
US10758571B1 (en) 2019-04-09 2020-09-01 Combangio, Inc. Processes for making and using a mesenchymal stem cell derived secretome
WO2021207282A2 (en) 2020-04-07 2021-10-14 Combangio, Inc. Lyophilized mesenchymal stem cell derived secretome and uses thereof
CN115998845B (zh) * 2020-10-26 2026-04-10 上海交通大学医学院附属第九人民医院 血小板反应蛋白1在制备预防和/或治疗视网膜损伤的药物中的应用
CN115177717B (zh) * 2022-08-31 2026-02-06 贵州医科大学附属医院 一种治疗眼表及角膜上皮疾病的药物
CN117004554B (zh) * 2023-08-09 2026-01-06 北京燕麝生物科技发展有限公司 一种林麝香腺细胞的培养基及林麝香腺细胞的培养方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8790637B2 (en) * 2003-06-27 2014-07-29 DePuy Synthes Products, LLC Repair and regeneration of ocular tissue using postpartum-derived cells
ES2569780T3 (es) * 2003-06-27 2016-05-12 DePuy Synthes Products, Inc. Células posparto derivadas de tejido placentario y métodos de preparación y uso de las mismas
US9572840B2 (en) * 2003-06-27 2017-02-21 DePuy Synthes Products, Inc. Regeneration and repair of neural tissue using postpartum-derived cells
US20130251670A1 (en) * 2011-09-13 2013-09-26 Aidan Products, Inc Treatment of Macular Edema Utilizing Stem Cell and Conditioned Media Thereof

Also Published As

Publication number Publication date
BR112017012581A2 (pt) 2017-12-26
CN107249608A (zh) 2017-10-13
PH12017501028A1 (en) 2018-03-05
US20160166619A1 (en) 2016-06-16
WO2016099949A2 (en) 2016-06-23
TW201632620A (zh) 2016-09-16
RU2017124983A3 (cg-RX-API-DMAC10.html) 2019-06-05
JP2018500325A (ja) 2018-01-11
EP3233096A2 (en) 2017-10-25
KR20170094368A (ko) 2017-08-17
SG11201704668PA (en) 2017-07-28
EP3233096A4 (en) 2018-08-22
CA2970641A1 (en) 2016-06-23
MX2017007953A (es) 2018-02-09
AU2015363088A1 (en) 2017-06-15
RU2017124983A (ru) 2019-01-17

Similar Documents

Publication Publication Date Title
IL285258A (en) Retinal ganglion cells and their progenitor cells
SG11201704668PA (en) Treatment of retinal degeneration using progenitor cells
IL251468A0 (en) aav-based gene therapy
IL253244B1 (en) Methods for treating retinal diseases
GB201403260D0 (en) Treatment of retinal degeneration using gene therapy
GB201701673D0 (en) Methods of well treatment
IL247515A0 (en) Snekribirock for the treatment of leprosy
PL3204105T3 (pl) Wszczepialny układ elektrodowy
PL3851537T3 (pl) Leczenie hiperbilirubinemii
EP3145875A4 (en) Electrochemical treatment methods
EP3213762A4 (en) Novel treatment of cornea using laminin
IL251013A0 (en) Implantable electrode
PL3233174T3 (pl) Wewnątrzgałkowe dostarczanie bioaktywnych cząsteczek za pomocą jontoforezy
EP3213761A4 (en) Novel treatment of retina and nerve using laminin
GB201416832D0 (en) Methods of treatment
ZA201704521B (en) Treatment of ocular conditions using progenitor cells
HUE042383T2 (hu) Beültethetõ elektróda elrendezés
ZA201608406B (en) Enzyme treatment composition
EP3384009A4 (en) TREATMENT OF NETWORK SKIN DISPOSAL WITH PRECURSOR CELLS
GB201601456D0 (en) Improvements relating to retinal treatment
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201407806D0 (en) Treatment of fibrosis
HK1262170A1 (en) Treatment of retinal degeneration using progenitor cells
ZA201608404B (en) Enzyme treatment composition
AU2014904206A0 (en) Treatment of fibrosis